Veterinary Molecular Diagnostics Market Size Report 2022 Top Companies, Industry Share, Growth Trends and Forecast to 2027 – San Juan Independent

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

According to the latest report by IMARC Group, titled “Global Veterinary Molecular Diagnostics Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027“, the global veterinary molecular diagnostics market reached a value of US$581.4 million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$1,064.1 million by 2027 exhibiting a CAGR of 9.40% during 2022-2027.

Veterinary molecular diagnostics refer to advanced laboratory techniques used to analyze the RNA, DNA, or other proteins in animals for disease diagnosis. Some commonly employed molecular-based methods include conventional, singleplex, multiplex, quantitative, and real-time polymerase chain reaction (PCR). They are utilized to identify, detect, and genotype various viral, bacterial, and vector-borne pathogens among animals. They require small amounts of a diverse spectrum of biological sample types and enable rapid and highly sensitive detection of nucleic acids to diagnose infectious diseases. As a result, veterinary molecular diagnostics find extensive applications in veterinary health centers and research laboratories.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample for more detailed market insights:

Report Metric
Historical: 2016-2021
Base year: 2021
Forecast Year: 2022-2027

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these top key players include:

  • Biochek B.V.,
  • bioMerieux SA,
  • HealthGene Corporation,
  • Heska Corporation,
  • IDEXX Laboratories Inc.,
  • Ingenetix GmbH,
  • NEOGEN Corporation,
  • Qiagen N.V.,
  • Thermo Fisher Scientific Inc.,
  • Veterinary Molecular Diagnostics Inc.
  • Zoetis Inc.

Important attributes and highlights of the report:

  • Detailed analysis of the market share
  • Market segmentation
  • Historical, current, and projected size of the market in terms of volume and value
  • Latest industry trends and developments
  • Competitive Landscape
  • Strategies of major players and product offerings

Veterinary Molecular Diagnostics Market Trends and Drivers:

The global veterinary molecular diagnostics market is primarily driven by the widespread prevalence of zoonotic diseases and the surging pet ownership rates. Additionally, the growing animal husbandry activities and the rising concerns regarding food safety have augmented the product demand.

Besides this, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of PCR testing for analyzing the impact of the infection in animals. Along with this, several key players are launching customized reagents and kits and developing advanced genotyping techniques like whole-genome sequencing (WGS), which is catalyzing the market growth.

Other factors, including the escalating demand for animal-derived products, favorable government initiatives, increasing pet healthcare expenditure, and rising awareness about animal health and wellness, are also anticipated to drive the market further.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

Global Veterinary Molecular Diagnostics Market 2022-2027 Analysis and Segmentation:

The report has segmented the market on the basis of region, product, technology, animal type, disease type and end user.

Breakup by Product:

  • Kits and Reagents
  • instrument
  • Software and Services

Breakup by technology:

  • Real time PCR
  • microarray
  • DNA sequencing

Breakup by Animal Type:

  • Companion Animal
  • Livestock Animal

Breakup by disease type:

  • Vector-borne Diseases
  • respiratory pathogens
  • diarrhea pathogens
  • Others

Breakup by End User:

  • Veterinary Hospitals
  • Clinical Laboratories
  • Research Institutes

Breakup by region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Inquire Before Buying :

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT analysis
  • value chain
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports : scientific-evogene-ltd/

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800